Zinc levels in zinc-stabilized insulin are inhibitory to the growth of cells in vitro.
Adult human prostatic epithelium was cultured in a defined medium consisting of RPMI 1640 supplemented with transferrin, insulin, epidermal growth factor, dexamethasone, and vitamin A. In the presence of insulin, stabilized with zinc, maximum epithelial multiplication was obtained at an insulin concentration of 0.03 to 0.1 U/ml, corresponding to a zinc concentration of 1.4 X 10(-7) M. At higher insulin concentrations, growth stimulation declined. Zinc-free insulin, on the other hand, stimulated cell multiplication with an optimum concentration of 0.3 to 1.0 U/ml. At this concentration, the maximum growth was twice that obtained with zinc-stabilized insulin. Results demonstrate that growth inhibition caused by zinc limits the concentration of zinc-stabilized insulin, which can be used in serum-free, defined culture media.
D000368:Aged; D001769:Blood; D002455:Cell Division / Q000187:drug effects*; D002478:Cells, Cultured; D003470:Culture Media / Q000592:standards*; D004305:Dose-Response Relationship, Drug; D004355:Drug Stability; D004847:Epithelial Cells; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000166:cytology*; D015032:Zinc / Q000494:pharmacology*
D003470:Culture Media; D007328:Insulin; D015032:Zinc